Simple reaction time tasks given to patients living with glaucoma had different response times based on whether the task was visual or auditory, according to a new study published in the European ...

H-1337 is under clinical development by D. Western Therapeutics Institute and currently in Phase II for Open-Angle Glaucoma.

Background: To investigate the levels of nitric oxide (NO) markers in plasma and aqueous humour of patients with primary open angle glaucoma (POAG) and their relation to ocular perfusion pressure.

Dihydropyridine CCBs may raise the risk of glaucoma, suggests a study published in the Ophthalmology Glaucoma.A study was ...

Shanghai BDgene Therapeutics is a biotechnology company engaged in research and development of gene therapies for the treatment of genetic diseases. The company is headquartered in Shanghai City, ...

Some patients with ocular hypertension who develop primary open angle glaucoma experience rapid visual field loss.

Sigma-2 receptor modulation using exogenous ligands reduces cellular damage associated with central nervous system degeneration in age-related pathologies such as Alzheimer’s disease, Parkinson’s ...

Some people have labeled glaucoma as the quiet disease, until it steals your vision, and then there are symptoms. In this ...

METHODS The records of consecutive patients with GO referred in a 5 year period were studied and those selected, in which glaucoma medication had been prescribed, or a diagnosis of primary open angle ...

11 analysts have expressed a variety of opinions on Glaukos GKOS over the past quarter, offering a diverse set of opinions ...

It may not be something you like to talk about, but if you have gastrointestinal (GI) problems, your symptoms may be far more common than you think. According to data from the American ...